|
1
|
Ginsberg RJ, Kris K and Armstrong G:
Cancer of the lung. Principles and Practice of Oncology. DeVita VT,
Hellman S and Rosenberg SA: 4th edition. JB Lippincott Co;
Philadelphia, PA: pp. 673–682. 1993
|
|
2
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37:S9–S15. 2001. View Article : Google Scholar
|
|
3
|
Onn A, Choe DH, Herbst RS, et al:
Synchronous overexpression of epidermal growth factor receptor and
HER2-neu protein is a predictor of poor outcome in patients with
stage I non-small cell lung cancer. Clin Cancer Res. 10:136–143.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paez JG, Jänne PA, Lee JC, et al: EGFR
mutations in lung cancer: correlation with clinical response to
gefitinib therapy. Science. 304:1497–1500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lynch TJ, Bell DW, Sordella R, et al:
Activating mutations in the epidermal growth factor receptor
underlying responsiveness of non-small-cell lung cancer to
gefitinib. N Engl J Med. 350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fukuoka M, Wu Y-L, Thongprasert S, et al:
Biomarker analyses and first overall survival results from a phase
III, randomized, open-label, first-line study of gefitinib versus
carboplatin/paclitaxel in clinically selected patients with
advanced non-small-cell lung cancer in Asia (IPASS). J Clin Oncol.
29:2866–2874. 2011. View Article : Google Scholar
|
|
7
|
Liu W, Innocenti F, Wu MH, et al: A
functional common polymorphism in a Sp1 recognition site of the
epidermal growth factor receptor gene promoter. Cancer Res.
65:46–53. 2005.PubMed/NCBI
|
|
8
|
Liu W, Wu X, Zhang W, et al: Relationship
of EGFR mutations, expression, amplification, and polymorphisms to
epidermal growth factor receptor inhibitors in the NCI60 cell
lines. Clin Cancer Res. 13:6788–6795. 2007. View Article : Google Scholar
|
|
9
|
Brandt B, Meyer-Staeckling S, Schmidt H,
et al: Mechanisms of EGFR gene transcription modulation:
relationship to cancer risk and therapy response. Clin Cancer Res.
12:7252–7260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu W, Innocenti F, Chen P, et al:
Interethnic difference in the allelic distribution of human
epidermal growth factor receptor intron 1 polymorphism. Clin Cancer
Res. 9:1009–1012. 2003.PubMed/NCBI
|
|
11
|
Ma F, Sun T, Shi Y, et al: Polymorphisms
of EGFR predict clinical outcome in advanced non-small-cell lung
cancer patients treated with Gefitinib. Lung Cancer. 66:114–119.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu G, Gurubhagavatula S, Zhou W, et al:
Epidermal growth factor receptor polymorphisms and clinical
outcomes in non-small-cell lung cancer patients treated with
gefitinib. Pharmacogenomics J. 8:129–138. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tiseo M, Capelletti M, De Palma G, et al:
Epidermal growth factor receptor intron-1 polymorphism predicts
gefitinib outcome in advanced non-small cell lung cancer. J Thorac
Oncol. 3:1104–1111. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jou YS, Lo YL, Hsiao CF, et al:
Association of an EGFR intron 1 SNP with never smoking female lung
adenocarcinoma patients. Lung Cancer. 64:251–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Endo K, Konishi A, Sasaki H, et al:
Epidermal growth factor receptor gene mutation in non-small cell
lung cancer using highly sensitive and fast TaqMan PCR assay. Lung
Cancer. 50:375–384. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
De la Vega FM, Lazaruk KD, Rhodes MD and
Wenz MH: Assessment of two flexible and compatible SNP genotyping
platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping
System. Mutat Res. 573:111–135. 2005.PubMed/NCBI
|
|
17
|
Sasaki H, Okuda K, Shimizu S, et al: EGFR
R497K polymorphism is a favorable prognostic factor for advanced
lung cancer. J Cancer Res Clin Oncol. 135:313–318. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sasaki H, Shimizu S, Okuda K, et al:
Epidermal growth factor receptor gene amplification in surgical
resected Japanese lung cancer. Lung Cancer. 64:295–300. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cappuzzo F, Hirsch FR, Rossi E, et al:
Epidermal growth factor receptor gene and protein and gefitinib
sensitivity in non-small-cell lung cancer. J Natl Cancer Inst.
97:643–655. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sasaki H, Endo K, Takada M, et al: EGFR
exon 20 insertion mutation in Japanese lung cancer. Lung Cancer.
58:324–328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nie Q, Wang Z, Zhang GC, et al: The
epidermal growth factor receptor intron1 (CA) n microsatellite
polymorphism is a potential predictor of treatment outcome in
patients with advanced lung cancer treated with Gefitinib. Eur J
Pharmacol. 570:175–181. 2007. View Article : Google Scholar
|
|
22
|
Liu W, He L, Ramírez J, et al: Functional
EGFR germline polymorphisms may confer risk for EGFR somatic
mutations in non-small cell lung cancer, with a predominant effect
on exon 19 microdeletions. Cancer Res. 71:2423–2427. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suzuki M, Kageyama S, Shinmura K, et al:
Inverse relationship between the length of the EGFR CA repeat
polymorphism in lung carcinoma and protein expression of EGFR in
the carcinoma. J Surg Oncol. 98:457–461. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ichihara S, Toyooka S, Fujiwara Y, et al:
The impact of epidermal growth factor receptor gene status on
gefitinib-treated Japanese patients with non-small-cell lung
cancer. Int J Cancer. 120:1239–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nomura M, Shigematsu H, Li L, et al:
Polymorphisms, mutations, and amplification of the EGFR gene in
non-small cell lung cancers. PLos One. 4:715–727. 2007.PubMed/NCBI
|
|
26
|
Sasaki H, Okuda K, Takada M, et al: A
novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese
lung cancer. J Cancer Res Clin Oncol. 134:1371–1376. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Girard N, Lou E, Azzoli CG, et al:
Analysis of genetic variants in never-smokers with lung cancer
facilitated by an internet-based blood collection protocol: a
preliminary report. Clin Cancer Res. 16:755–763. 2010. View Article : Google Scholar : PubMed/NCBI
|
